These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19354028)

  • 61. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005.
    Pérez-Trallero E; Montes M; Orden B; Tamayo E; García-Arenzana JM; Marimón JM
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1228-33. PubMed ID: 17242142
    [TBL] [Abstract][Full Text] [Related]  

  • 62. T serotyping and genomic profile of erythromycin-resistant or -sensitive Streptococcus pyogenes isolated in Campania Region, Italy.
    Catalanotti P; Catania MR; Lucido M; Martini S; Gallè F; Ortega De Luna L; Rossano F
    J Chemother; 2005 Apr; 17(2):131-7. PubMed ID: 15920897
    [TBL] [Abstract][Full Text] [Related]  

  • 63. emm Gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes.
    Zampaloni C; Cappelletti P; Prenna M; Vitali LA; Ripa S
    J Clin Microbiol; 2003 Mar; 41(3):1307-10. PubMed ID: 12624074
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Resistance to macrolides in Group A streptococci from the European section of Turkey: genetic and phenotypic characterization.
    Akata F; Oztürk D; Tansel O; Tatman-Otkun M; Otkun M; Fitoussi F; Bingen E; Tugrul M
    Int J Antimicrob Agents; 2002 Dec; 20(6):461-3. PubMed ID: 12458142
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.
    York MK; Gibbs L; Perdreau-Remington F; Brooks GF
    J Clin Microbiol; 1999 Jun; 37(6):1727-31. PubMed ID: 10325315
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.
    Clancy J; Petitpas J; Dib-Hajj F; Yuan W; Cronan M; Kamath AV; Bergeron J; Retsema JA
    Mol Microbiol; 1996 Dec; 22(5):867-79. PubMed ID: 8971709
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany.
    Asmah N; Eberspächer B; Regnath T; Arvand M
    J Med Microbiol; 2009 Feb; 58(Pt 2):222-227. PubMed ID: 19141740
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.
    Seppälä H; Skurnik M; Soini H; Roberts MC; Huovinen P
    Antimicrob Agents Chemother; 1998 Feb; 42(2):257-62. PubMed ID: 9527769
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Resistance rates and phenotypic characterization of Streptococcus pyogenes in a paediatric population in Northern Spain (2005-2015)].
    Calle-Miguel L; Pérez-Méndez C; Miguel-Martínez MD; Lombraña-Álvarez E; García-García E; Solís-Sánchez G
    Rev Esp Quimioter; 2017 Apr; 30(2):90-95. PubMed ID: 28233483
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Current Streptococcus pyogenes sensitivity responsible for acute tonsillopharyngitis in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Presse Med; 2004 Jun; 33(11):703-6. PubMed ID: 15257225
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical and microbiological characteristics of severe infections caused by group A streptococci].
    Hupková H; Zaborská M; Sisovský V; Babál P; Simaljaková M; Koren M; Reis R; Kozáková J
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):164-7. PubMed ID: 25642472
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevalence of the internalization-associated gene prtF1 in a bacterial population of Streptococcus pyogenes isolated from children with acute pharyngotonsillitis before and after antibiotic therapy.
    Cocuzza CE; Lanzafame A; Sisto F; Broccolo F; Mattina R
    Microb Drug Resist; 2004; 10(3):264-8. PubMed ID: 15383172
    [TBL] [Abstract][Full Text] [Related]  

  • 73. cMLS and M phenotypes among Streptococcus pyogenes isolates in Chennai.
    Jacob SE; Lloyd CA; Menon T
    Indian J Med Microbiol; 2006 Apr; 24(2):147-8. PubMed ID: 16687873
    [No Abstract]   [Full Text] [Related]  

  • 74. Highly prevalent emmSTG840.0 and emmSTC839.0 types of erythromycin non-susceptible group G Streptococcus isolated from bacteremia in southern Taiwan.
    Zheng PX; Chan YC; Chiou CS; Hsieh CL; Chiang-Ni C; Wu JJ
    J Microbiol Immunol Infect; 2017 Dec; 50(6):831-838. PubMed ID: 28711431
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.
    Bingen E; Fitoussi F; Doit C; Cohen R; Tanna A; George R; Loukil C; Brahimi N; Le Thomas I; Deforche D
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1453-7. PubMed ID: 10817692
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Increasing methylase-mediated resistance to macrolides in Streptococcus pyogenes in a children's hospital in Barcelona (Spain)].
    Gené A; Ardanuy C; Palacín E; García-García JJ
    Enferm Infecc Microbiol Clin; 2006 Jan; 24(1):26-8. PubMed ID: 16537059
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes.
    Giovanetti E; Brenciani A; Burioni R; Varaldo PE
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3750-5. PubMed ID: 12435672
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
    Cornaglia G; Ligozzi M; Mazzariol A; Masala L; Lo Cascio G; Orefici G; Fontana R
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S87-92. PubMed ID: 9710676
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Conjugative transfer of the erm(A) gene from erythromycin-resistant Streptococcus pyogenes to macrolide-susceptible S. pyogenes, Enterococcus faecalis and Listeria innocua.
    Giovanetti E; Magi G; Brenciani A; Spinaci C; Lupidi R; Facinelli B; Varaldo PE
    J Antimicrob Chemother; 2002 Aug; 50(2):249-52. PubMed ID: 12161406
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Erythromycin-resistant Streptococcus pyogenes].
    Lazarević G; Laban-Nestorović S; Jovanović M; Potkonjak B
    Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():42-4. PubMed ID: 15615464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.